EGFR and neoplasm: By contrast, cetuximab-IRDye800CW (Cet-IRDye800CW), a conjugate of the anti-epidermal growth factor receptor (EGFR) monoclonal antibody cetuximab and the near-infrared dye IRDye800CW, combines molecular specificity with favorable optical properties, offering selective tumor visualization and deep tissue penetration.4